Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)Scott Evans, Henry F. Chambers, Sara E. Cosgrove et al.|Clinical Infectious Diseases|2015Cited by 340
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort studyMinggui Wang, H. R. Cross, Robert A. Bonomo et al.|The Lancet Infectious Diseases|2021Cited by 338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort studyDavid van Duin, Robert A. Bonomo, Michael J. Satlin et al.|The Lancet Infectious Diseases|2020Cited by 328
The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)Thomas P. Lodise, Thomas L Holland, Matthew Sims et al.|Clinical Infectious Diseases|2019Cited by 158
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream InfectionSarah B. Doernberg, Joshua S. Davis, Henry F. Chambers et al.|Clinical Infectious Diseases|2018Cited by 76